Literature DB >> 17241230

The development of intellectual abilities in pediatric temporal lobe epilepsy.

Francesca Cormack1, J Helen Cross, Elizabeth Isaacs, William Harkness, Ingram Wright, Faraneh Vargha-Khadem, Torsten Baldeweg.   

Abstract

PURPOSE: The aim of this study was to examine the impact of clinical variables, particularly age at onset of epilepsy, on intellectual function in a group of children with temporal lobe epilepsy (TLE).
METHODS: We reviewed the preoperative neuropsychological test results of 79 children with unilateral TLE who subsequently underwent surgical resection. The impact of age at onset and duration of epilepsy, pathology type, and side of resection on full-scale intelligence quotient (IQ) scores was examined.
RESULTS: Intellectual dysfunction (defined as IQ < 79) was present in 57% of children, and age at onset of epilepsy was the best predictor of intellectual function. Children with epilepsy onset in the first year of life had a particularly high incidence of intellectual impairment (82.4%).
CONCLUSION: These data suggest a critical period during the first year of life for the subsequent development of intellectual abilities and highlight the importance of early treatment in this population.

Entities:  

Mesh:

Year:  2007        PMID: 17241230     DOI: 10.1111/j.1528-1167.2006.00904.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  26 in total

1.  Risk and correlates of autism spectrum disorder in children with epilepsy: a community-based study.

Authors:  Anne T Berg; Sigita Plioplys; Roberto Tuchman
Journal:  J Child Neurol       Date:  2011-03-18       Impact factor: 1.987

2.  Abnormal white matter correlates with neuropsychological impairment in children with localization-related epilepsy.

Authors:  Elysa Widjaja; Jovanka Skocic; Cristina Go; O Carter Snead; Donald Mabbott; Mary Lou Smith
Journal:  Epilepsia       Date:  2013-05-07       Impact factor: 5.864

3.  Contributions of nonhuman primate research to understanding the consequences of human brain injury during development.

Authors:  Francesca Cacucci; Faraneh Vargha-Khadem
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

Review 4.  Starting at the beginning: the neuropsychological status of children with new-onset epilepsies.

Authors:  Bruce P Hermann; Jana E Jones; Daren C Jackson; Michael Seidenberg
Journal:  Epileptic Disord       Date:  2012-03       Impact factor: 1.819

Review 5.  Epilepsy and autism: is there a special relationship?

Authors:  Anne T Berg; Sigita Plioplys
Journal:  Epilepsy Behav       Date:  2012-02-29       Impact factor: 2.937

6.  Epilepsy among children and adolescents with autism spectrum disorders: a population-based study.

Authors:  Elina Jokiranta; Andre Sourander; Auli Suominen; Laura Timonen-Soivio; Alan S Brown; Matti Sillanpää
Journal:  J Autism Dev Disord       Date:  2014-10

7.  Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach.

Authors:  Agnies M van Eeghen; Margaret B Pulsifer; Vanessa L Merker; Ann M Neumeyer; Elmer E van Eeghen; Ronald L Thibert; Andrew J Cole; Fawn A Leigh; Scott R Plotkin; Elizabeth A Thiele
Journal:  Dev Med Child Neurol       Date:  2012-12-04       Impact factor: 5.449

8.  The neuropsychological and academic substrate of new/recent-onset epilepsies.

Authors:  Daren C Jackson; Kevin Dabbs; Natalie M Walker; Jana E Jones; David A Hsu; Carl E Stafstrom; Michael Seidenberg; Bruce P Hermann
Journal:  J Pediatr       Date:  2012-12-05       Impact factor: 4.406

Review 9.  Cognitive and magnetic resonance volumetric abnormalities in new-onset pediatric epilepsy.

Authors:  Bruce P Hermann; Jana Jones; Raj Sheth; Michael Seidenberg
Journal:  Semin Pediatr Neurol       Date:  2007-12       Impact factor: 1.636

10.  Effect of age on cognitive sequelae following early life seizures in rats.

Authors:  Havisha B Karnam; Qian Zhao; Tatiana Shatskikh; Gregory L Holmes
Journal:  Epilepsy Res       Date:  2009-04-22       Impact factor: 3.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.